Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylorieradication
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylorieradication ; volume:9 ; number:1 ; day:26 ; month:5 ; year:2009 ; pages:1-5 ; date:12.2009
BMC gastroenterology ; 9, Heft 1 (26.5.2009), 1-5, 12.2009
- Urheber
-
Eisig, Jaime N.
- Beteiligte Personen und Organisationen
-
Silva, Fernando M.
Barbuti, Ricardo C.
Rodriguez, Tomás Navarro
Malfertheiner, Peter
Filho, Moraes Joaquim PP
Zaterka, Schlioma
SpringerLink (Online service)
- DOI
-
10.1186/1471-230X-9-38
- URN
-
urn:nbn:de:1111-2016081211992
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Eisig, Jaime N.
- Silva, Fernando M.
- Barbuti, Ricardo C.
- Rodriguez, Tomás Navarro
- Malfertheiner, Peter
- Filho, Moraes Joaquim PP
- Zaterka, Schlioma
- SpringerLink (Online service)
Ähnliche Objekte (12)
Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
Esomeprazol-Levofloxacin-Amoxicillin-Tripel-Therapie der Helicobacter-pylori-Infektion bei bekannter Sensitivität von Helicobacter pylori
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal
Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial
Association between failed eradication of 7-day triple therapy for Helicobacter pylori and untreated dental caries in Japanese adults
Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains
Pilot study: Comparing efficacy of 14-day triple therapy Clarithromycin versus levofloxacin on eradication of Helicobacter Pylori infection in Syrian population single-center experience
Present-day English, [...]. Basic course, main course.
Present-day English, [...]. Basic course, main course
Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen
Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin
Efficacy of a 2-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial
Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
Esomeprazol-Levofloxacin-Amoxicillin-Tripel-Therapie der Helicobacter-pylori-Infektion bei bekannter Sensitivität von Helicobacter pylori
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal
Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial
Association between failed eradication of 7-day triple therapy for Helicobacter pylori and untreated dental caries in Japanese adults
Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains
Pilot study: Comparing efficacy of 14-day triple therapy Clarithromycin versus levofloxacin on eradication of Helicobacter Pylori infection in Syrian population single-center experience
Present-day English, [...]. Basic course, main course.
Present-day English, [...]. Basic course, main course
Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen
Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin
Efficacy of a 2-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial
Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
Esomeprazol-Levofloxacin-Amoxicillin-Tripel-Therapie der Helicobacter-pylori-Infektion bei bekannter Sensitivität von Helicobacter pylori
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal
Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial
Association between failed eradication of 7-day triple therapy for Helicobacter pylori and untreated dental caries in Japanese adults
Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains
Pilot study: Comparing efficacy of 14-day triple therapy Clarithromycin versus levofloxacin on eradication of Helicobacter Pylori infection in Syrian population single-center experience
Present-day English, [...]. Basic course, main course.
Present-day English, [...]. Basic course, main course
Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen
Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin